Correlation Between JPMorgan Chase and Aptose Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both JPMorgan Chase and Aptose Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining JPMorgan Chase and Aptose Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between JPMorgan Chase Co and Aptose Biosciences, you can compare the effects of market volatilities on JPMorgan Chase and Aptose Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in JPMorgan Chase with a short position of Aptose Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of JPMorgan Chase and Aptose Biosciences.

Diversification Opportunities for JPMorgan Chase and Aptose Biosciences

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between JPMorgan and Aptose is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding JPMorgan Chase Co and Aptose Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aptose Biosciences and JPMorgan Chase is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on JPMorgan Chase Co are associated (or correlated) with Aptose Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aptose Biosciences has no effect on the direction of JPMorgan Chase i.e., JPMorgan Chase and Aptose Biosciences go up and down completely randomly.

Pair Corralation between JPMorgan Chase and Aptose Biosciences

Assuming the 90 days trading horizon JPMorgan Chase Co is expected to generate 0.33 times more return on investment than Aptose Biosciences. However, JPMorgan Chase Co is 3.02 times less risky than Aptose Biosciences. It trades about 0.12 of its potential returns per unit of risk. Aptose Biosciences is currently generating about -0.22 per unit of risk. If you would invest  2,611  in JPMorgan Chase Co on September 3, 2024 and sell it today you would earn a total of  733.00  from holding JPMorgan Chase Co or generate 28.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

JPMorgan Chase Co  vs.  Aptose Biosciences

 Performance 
       Timeline  
JPMorgan Chase 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in JPMorgan Chase Co are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, JPMorgan Chase displayed solid returns over the last few months and may actually be approaching a breakup point.
Aptose Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aptose Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

JPMorgan Chase and Aptose Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with JPMorgan Chase and Aptose Biosciences

The main advantage of trading using opposite JPMorgan Chase and Aptose Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if JPMorgan Chase position performs unexpectedly, Aptose Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will offset losses from the drop in Aptose Biosciences' long position.
The idea behind JPMorgan Chase Co and Aptose Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Money Managers
Screen money managers from public funds and ETFs managed around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance